Please ensure Javascript is enabled for purposes of website accessibility

Why Can't IMAX Get Any Love?

By Travis Hoium – Updated Apr 6, 2017 at 5:26PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Why can't a company that grew throughout the recession get any love from investors?

When I made IMAX (NYSE: IMAX) my top stock pick for 2011, I saw a great value in a growth stock that could generate returns for years to come. Through the first few months of the year, that pick looked genius as the company signed big deals to add theaters in China -- and the stock kept rising.

But the shine has worn off IMAX, and after three disappointing earnings reports and a slew of mediocre movies, the stock is back where it traded in the summer of 2010.

Imax Corporation Stock Chart

Imax Corporation Stock Chart by YCharts.

But there are still plenty of reasons to like IMAX, reasons I think the market is overlooking.

It's all about the movies
IMAX thrives on a specific type of action film, and 2010 was a historically good year for IMAX-type movies. You needed to look no further than Avatar for a movie that could make investors smile for the entire year. But 2011 has been the opposite with films like Super 8, Contagion, Real Steel, and Puss in Boots. Outside of Harry Potter and Transformers, the year has been mostly a dud.

But that might be turning around with a few upcoming films. Mission Impossible: Ghost Protocol opens in IMAX theaters five days before regular theaters and should be just the kind of film the company needs. Next year, we have new editions of Time Warner's (NYSE: TWX) Batman, as well as Sony's (NYSE: SNE) Spider-Man and Men in Black, all movies that are built for IMAX. So as bad as 2011 has been, there may be light at the end of the tunnel.

International is key
IMAX's international growth is just beginning, with 85 to 90 theaters expected to be open in China by year's end and a backlog of over 100 more theaters. That's up from 40 open theaters to end 2010. And international per-screen average box office is 1.9 times what IMAX gets in the U.S., where it still outpaces traditional theaters by a wide margin.

International films are now being released in IMAX as well, another growth avenue for the company. IMAX has had a slower, more measured approach to expansion -- unlike RealD (NYSE: RLD) in the 3-D arena, which expanded as quickly as possible -- but the pace is beginning to pick up, and that should be a positive for investors.

Foolish bottom line
This year has been rough for IMAX, but I think there are a lot of positives to look forward to as the calendar flips to 2012. Theater growth is picking up pace, blockbuster movies appear to be lining up in IMAX's favor, and the stock is trading at a more attractive level than it was a few months ago.

Interested in reading more about IMAX? Click here to add it to My Watchlist, which will find all of our Foolish analysis on this stock.

Fool contributor Travis Hoium owns shares of IMAX. You can follow Travis on Twitter at @FlushDrawFool, check out his personal stock holdings or follow his CAPS picks at TMFFlushDraw.

Motley Fool newsletter services have recommended buying shares of IMAX. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

IMAX Corporation Stock Quote
IMAX Corporation
IMAX
$13.87 (0.73%) $0.10
Time Warner Inc. Stock Quote
Time Warner Inc.
TWX
Sony Corporation Stock Quote
Sony Corporation
SONY
$68.43 (-1.37%) $0.95

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
339%
 
S&P 500 Returns
109%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.